Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging

被引:117
作者
Rossi, Derrick J.
Seita, Jun
Czechowicz, Agnieszka
Bhattacharya, Deepta
Bryder, David
Weissman, Irving L.
机构
[1] Stanford Univ, Sch Med, Satnford Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA
[2] Lund Univ, Inst Expt Med Sci, S-22100 Lund, Sweden
关键词
quiescent; aging; genomic instability; hematopoietic; genomic maintenance;
D O I
10.4161/cc.6.19.4759
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aging of tissue-specific stem and progenitor cells is believed to be central to the pathophysiological conditions arising in aged individuals. While the mechanisms driving stem cell aging are poorly understood, mounting evidence points to age-dependent DNA damage accrual as an important contributing factor. While it has been postulated that DNA damage may deplete stem cell numbers with age, recent studies indicate that murine hematopoietic stem cell (HSC) reserves are in fact maintained despite the accrual of genomic damage with age. Evidence suggests this to be a result of the quiescent (G(0)) cell cycle status of HSC, which results in an attenuation of checkpoint control and DNA damage responses for repair or apoptosis. When aged stem cells that have acquired damage are called into cycle under conditions of stress or tissue regeneration however, their functional capacity was shown to be severely impaired. These data suggest that age-dependent DNA damage accumulation may underlie the diminished capacity of aged stem cells to mediate a return to homeostasis after acute stress or injury. Moreover, the cytoprotection afforded by stem cell quiescence in stress-free, steady-state conditions suggests a mechanism through which potentially dangerous lesions can accumulate in the stem cell pool with age.
引用
收藏
页码:2371 / 2376
页数:6
相关论文
共 59 条
  • [1] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
    Akashi, K
    Traver, D
    Miyamoto, T
    Weissman, IL
    [J]. NATURE, 2000, 404 (6774) : 193 - 197
  • [2] Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation
    Allsopp, RC
    Morin, GB
    DePinho, R
    Harley, CB
    Weissman, IL
    [J]. BLOOD, 2003, 102 (02) : 517 - 520
  • [3] Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells
    Allsopp, RC
    Morin, GB
    Horner, JW
    DePinho, R
    Harley, CB
    Weissman, IL
    [J]. NATURE MEDICINE, 2003, 9 (04) : 369 - U6
  • [4] Cancer predisposition and hematopoietic failure in Rad50S/S mice
    Bender, CF
    Sikes, ML
    Sullivan, R
    Huye, LE
    Le Beau, MM
    Roth, DB
    Mirzoeva, OK
    Oltz, EM
    Petrini, JHJ
    [J]. GENES & DEVELOPMENT, 2002, 16 (17) : 2237 - 2251
  • [5] Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning
    Bhattacharya, D
    Rossi, DJ
    Bryder, D
    Weissman, IL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (01) : 73 - 85
  • [6] Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
    Blasco, MA
    Lee, HW
    Hande, MP
    Samper, E
    Lansdorp, PM
    DePinho, RA
    Greider, CW
    [J]. CELL, 1997, 91 (01) : 25 - 34
  • [7] Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect
    Bowie, Michelle B.
    McKnight, Kristen D.
    Kent, David G.
    McCaffrey, Lindsay
    Hoodless, Pamela A.
    Eaves, Connie J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (10) : 2808 - 2816
  • [8] Bradford GB, 1997, EXP HEMATOL, V25, P445
  • [9] Hematopoietic stem cells - The paradigmatic tissue-specific stem cell
    Bryder, David
    Rossi, Derrick J.
    Weissman, Irving L.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) : 338 - 346
  • [10] MUTATION SELECTION AND NATURAL-HISTORY OF CANCER
    CAIRNS, J
    [J]. NATURE, 1975, 255 (5505) : 197 - 200